Nodal melanoma metastasis under infliximab therapy in a patient with nevoid melanoma first misdiagnosed as benign nevus: A potentially dangerous diagnostic pitfall in the era of biologic therapies

6Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

We report the case of a 53-year-old Caucasian woman who developed nodal melanoma metastasis under infliximab therapy 2 years after the removal of a nevoid melanoma, which was initially misdiagnosed as a benign compound nevus. This case illustrates the potential link between tumor necrosis factor (TNF)- inhibition and the reactivation of latent melanoma. Furthermore, this case highlights the need for a complete skin examination before using anti-TNF- therapy to rule out atypical malignant lesions or melanomas that can easily be missed because of presentations such as nevoid melanoma. © 2013 S. Karger AG, Basel.

Cite

CITATION STYLE

APA

Safa, G., Fromentoux, S., Darrieux, L., Hogenhuis, J. A., & Tisseau, L. (2013). Nodal melanoma metastasis under infliximab therapy in a patient with nevoid melanoma first misdiagnosed as benign nevus: A potentially dangerous diagnostic pitfall in the era of biologic therapies. Case Reports in Dermatology, 5(3), 290–294. https://doi.org/10.1159/000355670

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free